Last quarter (Q3 2025), BriaCell Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, BriaCell Therapeutics's net income was $-6.13M. See BriaCell Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -114.04K	$ -20.49K	$ -19.39K	$ -19.44K	$ -18.74K
Operating Expenses	$ 46.02K	$ 23.27M	$ 19.58K	$ 6.97M	$ 3.92M
Depreciation and Amortization	-	$ 15.27K	$ 15.27K	$ 15.26K	$ 15.26K
EBITDA	$ -45.91K	$ -27.23M	$ -34.05M	$ -6.95M	$ -4.89M
Operating Income	$ -46.02K	$ -23.27M	$ -15.29M	$ -6.97M	$ -3.94M
Other Income/Expenses	$ 39.21K	$ 2.97M	$ -11.69M	$ -8.54K	$ -113.00
Pretax Income	$ -6.81K	$ -20.30M	$ -26.84M	$ -13.82M	$ -4.03M
Net Income	$ -6.62K	$ -20.30M	$ -11.58M	$ -2.90M	$ 1.39M
Per Share Metrics
Basic EPS	$ -4.28	$ -19.79	$ -25.70	$ -46.73	$ -77.53
Diluted EPS	$ -4.28	$ -19.79	$ -25.70	$ -46.73	$ -77.53
Weighted Average Shares Outstanding	1.10M	1.04M	1.03M	301.31K	47.59K
Weighted Average Shares Outstanding (Diluted)	1.10M	1.04M	1.03M	301.31K	47.59K

Currency in USD

BriaCell Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing